Activity Overview

The US Centers for Disease Control (CDC) analysis of the 1999-2004 National Health and Nutrition Examination Survey (NHANES) data found that almost 17% of the US population aged >20 years had chronic kidney disease (CKD), and 12% of noninstitutionalized US adults have diagnosed cardiovascular disease (CVD). Although unfortunately underappreciated and malcomprehended by the general healthcare system, these 2 disease often present as comorbidities. As a result, and for many reasons, patients who present with any degree of CKD and/or CVD are often not seen by the most appropriate medical carer, are not treated intensively enough by the carers they do see, and/or are not referred rapidly enough to the appropriate level of medical care. This means that for many patients who present with earlier forms of renal disease (stages 1 – 3 renal disease) and who often have concomitant CVD, they are not treated rapidly and intensively enough to prevent either their progression on to more serious renal disease (stages 3 -5 CKD or even end-stage renal disease [ESRD]) or, more likely, to worsening CVD morbidity and even death. This registers the clear need for physicians from the different relevant specialties to interact with each other in this educational forum, Multispecialty Approaches to Patients with Comorbid Chronic Kidney Disease and Cardiovascular Disease, in order to present a comprehensive review of how each specialty should recognize, respond to, and refer for these comorbid conditions.

Target Audience

The educational design of this activity addresses the needs of Internal Medicine Providers, Cardiologists, and Nephrologists involved in the treatment of patients with Cardiovascular disease, Dyslipidemia, Renal Impairment, and Chronic Kidney Disease.

Learning Objectives

Upon completion of this activity, participants should be better able to:
  • Review the demographics, epidemiology and inter-relationships of chronic kidney disease, cardiovascular disease and dyslipidemia.
  • Recognize the risks of chronic kidney disease progression and cardiovascular disease in patients who are at risk for, or already presenting with, these comorbid conditions.
  • Describe the challenges of treating concomitant chronic kidney disease and dyslipidemia patients, based on limited available evidence-based medical approaches relative to the general population.


Joseph Vassalotti, MD, FASN
Chief Medical Officer
National Kidney Foundation
Associate Clinical Professor of Medicine
Mount Sinai School of Medicine
New York, NY
George Bakris, MD, FAHA, FASN
Professor of Medicine
Hypertensive Diseases Unit, Department of Medicine
University of Chicago-Pritzker School of Medicine
Chicago, IL
Peter Jones, MD
Associate Professor of Medicine
Atherosclerosis and Lipid Research
Baylor College of Medicine
Houston, Texas
Michael J. Bloch, MD
Associate Professor
Department of Internal Medicine
University of Nevada School of Medicine
Reno, Nevada

View Program and Claim
Continuing Education Credit
View Program without
Continuing Education Credit